HEADER ISOMERASE/ISOMERASE INHIBITOR 08-JUL-14 4TYO TITLE PPIASE IN COMPLEX WITH A NON-PHOSPHATE SMALL MOLECULE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PPIASE DOMAIN, UNP RESIDUES 45-163; COMPND 5 SYNONYM: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE PIN1,PPIASE PIN1, COMPND 6 ROTAMASE PIN1; COMPND 7 EC: 5.2.1.8; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIN1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SBDD, PPIASE, CELL CYCLE, ISOMERASE, SMALL MOLECULE, NUCLEUS, KEYWDS 2 PHOSPHOPROTEIN, ROTAMASE, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE, KEYWDS 3 ISOMERASE-ISOMERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,R.A.FERRE REVDAT 3 22-NOV-17 4TYO 1 SOURCE JRNL REMARK REVDAT 2 01-OCT-14 4TYO 1 JRNL REVDAT 1 20-AUG-14 4TYO 0 JRNL AUTH C.GUO,X.HOU,L.DONG,J.MARAKOVITS,S.GREASLEY,E.DAGOSTINO, JRNL AUTH 2 R.FERRE,M.CATHERINE JOHNSON,P.S.HUMPHRIES,H.LI,G.D.PADERES, JRNL AUTH 3 J.PIRAINO,E.KRAYNOV,B.W.MURRAY JRNL TITL STRUCTURE-BASED DESIGN OF NOVEL HUMAN PIN1 INHIBITORS (III): JRNL TITL 2 OPTIMIZING AFFINITY BEYOND THE PHOSPHATE RECOGNITION POCKET. JRNL REF BIOORG.MED.CHEM.LETT. V. 24 4187 2014 JRNL REFN ESSN 1464-3405 JRNL PMID 25091930 JRNL DOI 10.1016/J.BMCL.2014.07.044 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 21137 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1079 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.11 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2504 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2393 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2365 REMARK 3 BIN R VALUE (WORKING SET) : 0.2376 REMARK 3 BIN FREE R VALUE : 0.2672 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.55 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 139 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1778 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 161 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.06600 REMARK 3 B22 (A**2) : -1.10880 REMARK 3 B33 (A**2) : 2.17490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.49760 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.134 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.117 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.131 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.115 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1935 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2628 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 692 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 53 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 360 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1935 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 241 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2487 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.10 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.87 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TYO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-14. REMARK 100 THE DEPOSITION ID IS D_1000202414. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 193.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21138 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 3.750 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : 0.06300 REMARK 200 FOR THE DATA SET : 32.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.05000 REMARK 200 R SYM FOR SHELL (I) : 0.50100 REMARK 200 FOR SHELL : 2.710 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10MM DTT, 100MM HEPES, 0.1% (V/V) NP REMARK 280 -40, 1.6M NACITRATE. COMPOUND IN 5%DMSO SOAKED IN TO APO REMARK 280 CRYSTALS @ 250UM., PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 58.77950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.26250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 58.77950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.26250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 HIS A 43 REMARK 465 MET A 44 REMARK 465 GLY A 45 REMARK 465 LYS A 46 REMARK 465 ASN A 47 REMARK 465 GLY A 48 REMARK 465 GLN A 49 REMARK 465 GLY A 50 REMARK 465 GLY B 41 REMARK 465 SER B 42 REMARK 465 HIS B 43 REMARK 465 MET B 44 REMARK 465 GLY B 45 REMARK 465 LYS B 46 REMARK 465 ASN B 47 REMARK 465 GLY B 48 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 69 NE CZ NH1 NH2 REMARK 470 LYS A 117 CD CE NZ REMARK 470 GLN B 94 CG CD OE1 NE2 REMARK 470 LYS B 95 CD CE NZ REMARK 470 LYS B 117 CD CE NZ REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 39X A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 39X B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3I6C RELATED DB: PDB REMARK 900 SAME PROTEIN CONSTRUCT WITH SMALL MOLECULE ANALOG INHIBITORS BOUND. REMARK 900 RELATED ID: 3JYJ RELATED DB: PDB REMARK 900 RELATED ID: 3IKG RELATED DB: PDB REMARK 900 RELATED ID: 3IK8 RELATED DB: PDB REMARK 900 RELATED ID: 3IKD RELATED DB: PDB DBREF 4TYO A 45 163 UNP Q13526 PIN1_HUMAN 45 163 DBREF 4TYO B 45 163 UNP Q13526 PIN1_HUMAN 45 163 SEQADV 4TYO GLY A 41 UNP Q13526 EXPRESSION TAG SEQADV 4TYO SER A 42 UNP Q13526 EXPRESSION TAG SEQADV 4TYO HIS A 43 UNP Q13526 EXPRESSION TAG SEQADV 4TYO MET A 44 UNP Q13526 EXPRESSION TAG SEQADV 4TYO GLN A 77 UNP Q13526 LYS 77 ENGINEERED MUTATION SEQADV 4TYO GLN A 82 UNP Q13526 LYS 82 ENGINEERED MUTATION SEQADV 4TYO GLY B 41 UNP Q13526 EXPRESSION TAG SEQADV 4TYO SER B 42 UNP Q13526 EXPRESSION TAG SEQADV 4TYO HIS B 43 UNP Q13526 EXPRESSION TAG SEQADV 4TYO MET B 44 UNP Q13526 EXPRESSION TAG SEQADV 4TYO GLN B 77 UNP Q13526 LYS 77 ENGINEERED MUTATION SEQADV 4TYO GLN B 82 UNP Q13526 LYS 82 ENGINEERED MUTATION SEQRES 1 A 123 GLY SER HIS MET GLY LYS ASN GLY GLN GLY GLU PRO ALA SEQRES 2 A 123 ARG VAL ARG CYS SER HIS LEU LEU VAL LYS HIS SER GLN SEQRES 3 A 123 SER ARG ARG PRO SER SER TRP ARG GLN GLU GLN ILE THR SEQRES 4 A 123 ARG THR GLN GLU GLU ALA LEU GLU LEU ILE ASN GLY TYR SEQRES 5 A 123 ILE GLN LYS ILE LYS SER GLY GLU GLU ASP PHE GLU SER SEQRES 6 A 123 LEU ALA SER GLN PHE SER ASP CYS SER SER ALA LYS ALA SEQRES 7 A 123 ARG GLY ASP LEU GLY ALA PHE SER ARG GLY GLN MET GLN SEQRES 8 A 123 LYS PRO PHE GLU ASP ALA SER PHE ALA LEU ARG THR GLY SEQRES 9 A 123 GLU MET SER GLY PRO VAL PHE THR ASP SER GLY ILE HIS SEQRES 10 A 123 ILE ILE LEU ARG THR GLU SEQRES 1 B 123 GLY SER HIS MET GLY LYS ASN GLY GLN GLY GLU PRO ALA SEQRES 2 B 123 ARG VAL ARG CYS SER HIS LEU LEU VAL LYS HIS SER GLN SEQRES 3 B 123 SER ARG ARG PRO SER SER TRP ARG GLN GLU GLN ILE THR SEQRES 4 B 123 ARG THR GLN GLU GLU ALA LEU GLU LEU ILE ASN GLY TYR SEQRES 5 B 123 ILE GLN LYS ILE LYS SER GLY GLU GLU ASP PHE GLU SER SEQRES 6 B 123 LEU ALA SER GLN PHE SER ASP CYS SER SER ALA LYS ALA SEQRES 7 B 123 ARG GLY ASP LEU GLY ALA PHE SER ARG GLY GLN MET GLN SEQRES 8 B 123 LYS PRO PHE GLU ASP ALA SER PHE ALA LEU ARG THR GLY SEQRES 9 B 123 GLU MET SER GLY PRO VAL PHE THR ASP SER GLY ILE HIS SEQRES 10 B 123 ILE ILE LEU ARG THR GLU HET 39X A 201 43 HET GOL A 202 6 HET 39X B 201 43 HET GOL B 202 6 HETNAM 39X 3-(6-FLUORO-1H-BENZIMIDAZOL-2-YL)-N-(NAPHTHALEN-2- HETNAM 2 39X YLCARBONYL)-D-ALANINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 39X 2(C21 H16 F N3 O3) FORMUL 4 GOL 2(C3 H8 O3) FORMUL 7 HOH *161(H2 O) HELIX 1 AA1 THR A 81 GLY A 99 1 19 HELIX 2 AA2 ASP A 102 SER A 111 1 10 HELIX 3 AA3 CYS A 113 ARG A 119 5 7 HELIX 4 AA4 GLN A 131 LEU A 141 1 11 HELIX 5 AA5 THR B 81 SER B 98 1 18 HELIX 6 AA6 ASP B 102 SER B 111 1 10 HELIX 7 AA7 CYS B 113 ARG B 119 5 7 HELIX 8 AA8 GLN B 131 ALA B 140 1 10 SHEET 1 AA1 4 ASP A 121 SER A 126 0 SHEET 2 AA1 4 ARG A 54 VAL A 62 -1 N CYS A 57 O LEU A 122 SHEET 3 AA1 4 GLY A 155 GLU A 163 -1 O ILE A 156 N VAL A 62 SHEET 4 AA1 4 VAL A 150 THR A 152 -1 N VAL A 150 O HIS A 157 SHEET 1 AA2 4 ASP B 121 PHE B 125 0 SHEET 2 AA2 4 VAL B 55 VAL B 62 -1 N VAL B 55 O PHE B 125 SHEET 3 AA2 4 ILE B 156 GLU B 163 -1 O LEU B 160 N SER B 58 SHEET 4 AA2 4 VAL B 150 PHE B 151 -1 N VAL B 150 O HIS B 157 SITE 1 AC1 12 HIS A 59 LEU A 61 LYS A 63 CYS A 113 SITE 2 AC1 12 SER A 114 SER A 115 LEU A 122 GLN A 131 SITE 3 AC1 12 PHE A 134 SER A 154 HIS A 157 HOH A 312 SITE 1 AC2 7 THR A 79 GLU A 84 VAL A 150 PHE A 151 SITE 2 AC2 7 HOH A 303 HOH A 314 HOH A 375 SITE 1 AC3 16 HIS B 59 LEU B 61 LYS B 63 ARG B 68 SITE 2 AC3 16 ARG B 69 CYS B 113 SER B 114 SER B 115 SITE 3 AC3 16 LEU B 122 GLN B 131 PHE B 134 SER B 154 SITE 4 AC3 16 GOL B 202 HOH B 307 HOH B 318 HOH B 341 SITE 1 AC4 7 ARG B 68 GLN B 129 GLN B 131 39X B 201 SITE 2 AC4 7 HOH B 303 HOH B 307 HOH B 309 CRYST1 117.559 36.525 51.251 90.00 100.82 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008506 0.000000 0.001626 0.00000 SCALE2 0.000000 0.027379 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019865 0.00000 MASTER 282 0 4 8 8 0 11 6 0 0 0 20 END